Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 116,142
  • Shares Outstanding, K 6,445
  • Annual Sales, $ 118,710 K
  • Annual Income, $ -30,380 K
  • EBIT $ 10 M
  • EBITDA $ 41 M
  • 60-Month Beta 0.43
  • Price/Sales 0.98
  • Price/Cash Flow 1,102.12
  • Price/Book 1.23

Options Overview Details

View History
  • Implied Volatility 0.00% (unch)
  • Historical Volatility 72.81%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 748.29% on 12/23/25
  • IV Low 0.00% on 04/10/26
  • Expected Move (DTE 4) 5.65 (31.37%)
  • Put/Call Vol Ratio 1.70
  • Today's Volume 27
  • Volume Avg (30-Day) 187
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 5,398
  • Open Int (30-Day) 6,448
  • Expected Range 12.37 to 23.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-1.91
  • Number of Estimates 1
  • High Estimate $-1.91
  • Low Estimate $-1.91
  • Prior Year $-2.10
  • Growth Rate Est. (year over year) +9.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.28 +59.75%
on 03/17/26
20.45 -11.88%
on 03/26/26
+6.48 (+56.15%)
since 03/13/26
3-Month
9.91 +81.84%
on 01/14/26
20.45 -11.88%
on 03/26/26
+7.69 (+74.36%)
since 01/13/26
52-Week
8.55 +110.72%
on 04/22/25
20.45 -11.88%
on 03/26/26
+8.72 (+93.76%)
since 04/11/25

Most Recent Stories

More News
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Assertio Holdings ...

ASRT : 18.02 (unch)
ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior...

ASRT : 18.02 (unch)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Assertio Holdings, Inc. (NASDAQ: ASRT)

NEW YORK , April 9, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

ASRT : 18.02 (unch)
Assertio Announces Agreement to be Acquired by Garda Therapeutics

All-Cash Tender Offer of $18 per share – or $125.1 Million – Plus Contingent Value Right Tender Offer Price Represents 34.6% Premium to Unaffected...

ASRT : 18.02 (unch)
Assertio: Q4 Earnings Snapshot

Assertio: Q4 Earnings Snapshot

ASRT : 18.02 (unch)
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results

Delivers FY2025 Net Product Sales and Adjusted EBITDA Above Guidance Expects Net Product Sales between $110M-$125M and Adjusted EBITDA between $28M-$40M...

ASRT : 18.02 (unch)
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Assertio Holdings, Inc. (“Assertio”) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2025 financial results on Monday, March 16, 2026, after the market close. Following...

ASRT : 18.02 (unch)
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained...

ASRT : 18.02 (unch)
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

Peer-reviewed publication in “The Oncologist” is now available online Investigational same-day dosing of Rolvedon demonstrated a clinical response and adverse event...

ASRT : 18.02 (unch)
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split

Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it filed a certificate of amendment to its certificate of incorporation (the “Certificate of Amendment”)...

ASRT : 18.02 (unch)

Business Summary

Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 18.15
2nd Resistance Point 18.13
1st Resistance Point 18.07
Last Price 18.02
1st Support Level 17.99
2nd Support Level 17.97
3rd Support Level 17.91

See More

52-Week High 20.45
Last Price 18.02
Fibonacci 61.8% 15.90
Fibonacci 50% 14.50
Fibonacci 38.2% 13.10
52-Week Low 8.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.